Mary Ruppe

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24…

Journal of Bone and Mineral Research · 2018 · 274 citations

Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice

Brain Research · 1994 · 248 citations